SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACMI - Accumed Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dana Winrow who wrote (977)1/8/1998 11:53:00 AM
From: Frank Buck  Read Replies (3) of 1894
 
Dana,

About three years ago I watched a television segment on H.P.V., H.P.V.- testing and cervical-cancer. The segment depicted on-going technologies and various interviews with various researchers in the field. The general summation of the program indicated that a vaccine would be available for H.P.V. by the year 2000.

One of the Eurogin-papers discusses certain aspects of the vaccines.

Section 8: Prevention and Therapy by Immunization: Human Papillomavirus Vaccines and Their Potential use in the Prevention and Treatment of Cervical Neoplasia Animal Models for Evaluation of Human Papillomavirus Vaccines

blackwell-science.com

As I have not had an opportunity to obtain this paper as of yet, and have not heard any recent mention of an H.P.V. vaccine until discovering this above source, I was wondering........

What is the current status of the development of an H.P.V- vaccine and aside from the obvious beneficial humanitarian aspects of this vaccine, how would the development of an H.P.V. vaccine impact the industry and AccuMed in particular? Is the television segment time-table reasonable in regard to the vaccine?

Thanks in advance for your reply.

Frank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext